Injectable Hydrogel for Cu<sup>2+</sup> Controlled Release and Potent Tumor Therapy.

Life (Basel) · 2021 · PMC8147102 · PMID 33925834

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

Taken together, the CRC-based drug delivery approach is a highly significant and candidate therapeutic approach against cancer and might decrease systemic toxicity of copper ion therapy.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.